The role of immunohistochemical CIC expression in oligodendrogliomas for recurrence risk stratification

Clinical Neuropathology 2026

View at publisher
Authors: Elif Dogan Kabadayi, Mehmet Arda Temena, Fevziye İlknur Kayalı, Havva Beyaz, Deniz Belen, Servet Guresci
DOI: 10.5414/np301713
Cited by: 0

Abstract

; loss, 19q polysomy, and elevated mitotic activity may function as valuable prognostic indicators in ODGs. These features could improve risk stratification and guide personalized therapeutic strategies in otherwise favorable cases.

Fields of Study & Subjects

Glioma Diagnosis and Treatment Ovarian cancer diagnosis and treatment Chronic Lymphocytic Leukemia Research

Publication details

Journal / source
Clinical Neuropathology
Volume
45
Issue
01
Pages
2–9
Publication date
1 January 2026
Language
EN